Patients with a history of cancer, or those with elevated cancer risk, should approach peptide therapy with particular caution and only under close medical supervision
Liepinsh E, Makrecka-Kuka M, Kuka J, Vilskersts R, Makarova E, Cirule H, et al
Over a period of three months, liposomal glutathione supplementation supported the reduction of oxidative stress and mycobacterial burden in patients, as well as supported the modulation of inflammatory cytokines [11].* Another study demonstrated that immune function markers were enhanced, including NK cell cytotoxicity and lymphocyte proliferation, after liposomal glutathione was administered to study participants for just two weeks [12]
GLP-1 receptor agonists the treatment of type 2 diabetes: state-of-the-art
went toward caring for people with chronic diseases